LANDSCAPE CAPITAL MANAGEMENT, L.L.C.
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1536186
Englewood, NJ
Position in MDGL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$4,426,460
+$3,792,875 QoQ
Shares Held
8,456
+677.2% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LANDSCAPE CAPITAL MANAGEMENT, L.L.C. holds $27,332,699 across 24 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
30,353 | $4,044,839 | |
| 2 | INSM |
INSMED Inc
|
31,345 | $3,342,003 | |
| 3 | NKTR |
Nektar Therapeutics
|
41,902 | $2,925,177 | |
| 4 | CYTK |
Cytokinetics Inc
|
24,734 | $2,107,088 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
25,623 | $2,088,529 | |
| 6 | INCY |
Incyte Corp
|
17,004 | $1,927,572 | |
| 7 | TENX |
Tenax Therapeutics, Inc.
|
132,272 | $1,924,555 | |
| 8 | TECH |
BIO-TECHNE Corp
|
25,757 | $1,819,732 |
All Filings in MDGL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,426,460 | 8,456 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $633,585 | 1,088 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $463,245 | 1,010 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,773,469 | 5,860 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,221,558 | 6,707 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,118,257 | 3,624 | Shares | Defined | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||